Related Experiment Video
Updated: Jan 31, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors
Emil Chteinberg1,2,3, Faisal Klufah1,4, Dorit Rennspiess1
1Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Background:
The etiology of thymic epithelial tumors is unknown. Murine polyomavirus strain PTA has been shown to induce thymomas in mice. Recently, using diverse molecular techniques, we reported the presence of human polyomavirus 7 (HPyV7) in thymic epithelial tumors. In the present study, we investigated the prevalence of Merkel cell polyomavirus (MCPyV) in thymic epithelial tumors.
Methods:
Thirty-six thymomas were screened for MCPyV by PCR and subsequently tested by DNA and RNA in situ hybridization and immunohistochemistry. Twenty-six thymomas were diagnosed with myasthenia gravis (MG).
Results:
MCPyV DNA was detected by PCR in 7 (19.4%) of the 36 thymic epithelial tumors and in six of these, the presence of MCPyV was confirmed by fluorescence situ hybridization. Of these, 3 (28.6%) revealed weak MCPyV LT-antigen protein expression. In addition, one of the MCPyV positive thymomas tested positive for MCPyV LT RNA with RNAscope. Of interest, two out of the three thymomas that previously tested positive for MCPyV by immunohistochemistry also tested positive for HPyV7. One of the 11 MG-negative and 2 of the 25 MG-positive were positive for MCPyV.
Conclusions:
MCPyV DNA and MCPyV protein expression can be detected in human epithelial thymoma; however, to a far lesser extent than HPyV7. Our data strongly indicate that because of its infrequent detection and weak expression, MCPyV is unlikely to play an important role in the etiopathogenesis of human thymomas.
Insights
Merkel cell polyomavirus (MCPyV) DNA and protein were detected in a small percentage of human thymic epithelial tumors. However, infrequent detection and weak expression suggest MCPyV is unlikely to be a major cause of thymomas.
Area of Science:
- Oncology
- Virology
- Pathology
Background:
- The causes of thymic epithelial tumors remain unknown.
- Murine polyomavirus induces thymomas in mice.
- Human polyomavirus 7 (HPyV7) has been previously identified in thymic epithelial tumors.
Purpose of the Study:
- To investigate the prevalence of Merkel cell polyomavirus (MCPyV) in thymic epithelial tumors.
- To assess the potential role of MCPyV in the development of thymomas.
Main Methods:
- Screening of 36 thymomas for MCPyV using PCR.
- Confirmation of MCPyV presence via DNA and RNA in situ hybridization.
- Detection of MCPyV large tumor antigen (LT) protein expression using immunohistochemistry.
Main Results:
- MCPyV DNA was detected in 19.4% of thymic epithelial tumors.
- MCPyV LT-antigen protein expression was weak and detected in only 3 tumors.
- Co-detection of MCPyV and HPyV7 occurred in some cases.
Conclusions:
- MCPyV DNA and protein are detectable in human thymic epithelial tumors but at a lower frequency than HPyV7.
- The infrequent detection and weak expression of MCPyV suggest it plays a minor role in thymoma pathogenesis.
More Related Videos
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Classification of Epithelial Tissues: Overview
Based on the number of cell layers,...
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

